Independent Advisor Alliance Acquires 25 Shares of Chemed Co. (NYSE:CHE)

Independent Advisor Alliance grew its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,279 shares of the company’s stock after acquiring an additional 25 shares during the quarter. Independent Advisor Alliance’s holdings in Chemed were worth $1,207,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in CHE. State Street Corp raised its position in Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock worth $279,063,000 after purchasing an additional 3,564 shares during the period. Geode Capital Management LLC grew its stake in shares of Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after buying an additional 15,791 shares during the last quarter. Impax Asset Management Group plc increased its holdings in shares of Chemed by 4.7% in the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after buying an additional 14,814 shares during the period. Boston Trust Walden Corp lifted its stake in shares of Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after acquiring an additional 22,105 shares during the last quarter. Finally, FMR LLC boosted its holdings in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after acquiring an additional 45,917 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.32% of the company’s stock.

Chemed Trading Up 1.4 %

Chemed stock opened at $598.15 on Friday. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The firm has a market cap of $8.76 billion, a P/E ratio of 30.22, a P/E/G ratio of 2.15 and a beta of 0.43. The firm has a 50-day moving average of $559.02 and a 200-day moving average of $564.62.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed’s dividend payout ratio is currently 10.05%.

Analyst Ratings Changes

A number of brokerages have commented on CHE. Royal Bank of Canada lifted their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Read Our Latest Stock Report on CHE

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.